(ARDX) - Earnings & Price History

ARDX: - 5.5, $253.83M, 0.15 (2.80%)

Sector: Healthcare - Industry: Biotechnology

Ardelyx, Inc. discovers, develops, and commercializes minimally-systemic therapeutics for the gastrointestinal (GI) tract to treat GI and cardio-renal diseases. Its lead product candidate is tenapanor, which is in Phase III clinical trial for the treatment of patients with constipation-predominant irritable bowel syndrome, as well as in Phase IIb clinical trial for the treatment of hyperphosphatemia or elevated serum phosphorus levels in patients with end-stage renal disease. The company is also developing RDX022, an oral, non-absorbed potassium-binder for the treatment of hyperkalemia or elevated serum potassium. Its drug candidates in earlier stages of research and development include RDX009, a secretagogue of glucagon-like peptide-1 and glucagon-like peptide-2; and RDX013, a small molecule drug candidate for hyperkalemia. It has a collaboration partnership with AstraZeneca AB for the

Past ARDX reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2016-11-15AMC14.915.2515.1514.6515.45-0.66%▲-1.65%-2.30%109.61K
2016-08-18BMO10.4210.3410.2710.2710.54-0.68%1.46%0.77%56.77K
2016-08-08AMC-0.7510.210.2910.189.9510.3-1.07%0.20%-0.87%93.41K
2016-05-09AMC-0.667.257.667.036.857.4-8.22%3.13%-5.35%159.43K
2016-03-04AMC-0.81
2016-02-24-0.829.8410.0910.019.6210.2-0.79%-1.70%-2.48%122.39K
2016-02-23-0.8210.0910.049.89.7610.51-2.39%2.96%0.50%137.01K
2015-11-12-0.4818.4218.119.8818.0919.889.83%▲-7.34%1.77%73.69K
2015-08-120.0918.2118.2518.2117.8219.06-0.22%-0.22%94.56K
2015-02-250.0216.0117.316.2214.7816.6303-6.24%-1.29%-7.46%116.20K
2015-02-05Ardelyx Inc-0.0515.9215.9515.9415.7316.2-0.06%-0.13%-0.19%82.60K
2014-11-06AMCArdelyx Inc0.02023.4924.0124.0123.224.76-2.17%-2.17%31.30K

Login | Register
Friday Nov 16, 2018   EST
Enter a Ticker:

Economic Calendar

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY257.6450.500.19%41,867,194

Upgrades/Downgrades